Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 239

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

Open access
van de Loosdrecht, A. A., Alhan, C., Bene, M. C., Della Porta, M. G., Drager, A. M., Feuillard, J., Font, P., Germing, U., Haase, D., Homburg, C. H., Ireland, R., Jansen, J. H., Kern, W., Malcovati, L., te Marvelde, J. G., Mufti, G. J., Ogata, K., Orfao, A., Ossenkoppele, G. J., Porwit, A., Preijers, F. W., Richards, S. J., Schuurhuis, G. J., Subira, D., Valent, P., van der Velden, V. H.J., Vyas, P., Westra, A. H., de Witte, T. M., Wells, D. A., Loken, M. R., Westers, T. M. · 2009 · Haematologica

Abstract

The myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more cell lineages and increased risk of evolution to acute myeloid leukemia (AML). Recent advances in immunophenotyping of hematopoietic progenitor and maturing cells in dysplastic bone marrow point to a useful role for multiparameter flow cytometry (FCM) in the diagnosis and prognostication of myelodysplastic syndromes. In March 2008, representatives from 18 European institutes participated in a European LeukemiaNet (ELN) workshop held in Amsterdam as a first step towards standardization of FCM in myelodysplastic syndromes. Consensus was reached regarding standard methods for cell sampling, handling and processing. The group also defined minimal combinations of antibodies to analyze aberrant immunophenotypes and thus dysplasia. Examples are altered numbers of CD34(+) precursors, aberrant expression of markers on myeloblasts, maturing myeloid cells, monocytes or erythroid precursors and the expression of lineage infidelity markers. When applied in practice, aberrant FCM patterns correlate well with morphology, the subclassification of myelodysplastic syndromes, and prognostic scoring systems. However, the group also concluded that despite strong evidence for an impact of FCM in myelodysplastic syndromes, further (prospective) validation of markers and immunophenotypic patterns are required against control patient groups as well as further standardization in multi-center studies. Standardization of FCM in myelodysplastic syndromes may thus contribute to improved diagnosis and prognostication of myelodysplastic syndromes in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3324/haematol.2009.005801

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 239

Metadata

Authors
van de Loosdrecht, A. A., Alhan, C., Bene, M. C., Della Porta, M. G., Drager, A. M., Feuillard, J., Font, P., Germing, U., Haase, D., Homburg, C. H., Ireland, R., Jansen, J. H., Kern, W., Malcovati, L., te Marvelde, J. G., Mufti, G. J., Ogata, K., Orfao, A., Ossenkoppele, G. J., Porwit, A., Preijers, F. W., Richards, S. J., Schuurhuis, G. J., Subira, D., Valent, P., van der Velden, V. H. J., Vyas, P., Westra, A. H., de Witte, T. M., Wells, D. A., Loken, M. R., & Westers, T. M.
Venue
Haematologica
Published
2009-06-22
Volume
94
Issue
8
Pages
1124-1134
ISSN
  • 0390-6078 (ISSN-L)
  • 1592-8721
OpenAlex
W2125458360
Cited by
239
References
1
FWCI
14.66
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. https://app.cochat.ai/papers/10.3324/haematol.2009.005801
The paper
van de Loosdrecht, A. A., Alhan, C., Bene, M. C., Della Porta, M. G., Drager, A. M., Feuillard, J., Font, P., Germing, U., Haase, D., Homburg, C. H., Ireland, R., Jansen, J. H., Kern, W., Malcovati, L., te Marvelde, J. G., Mufti, G. J., Ogata, K., Orfao, A., Ossenkoppele, G. J., . . . Westers, T. M. (2009). Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica. https://doi.org/10.3324/haematol.2009.005801

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.